Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tachycardia, Ventricular | 14 | 2023 | 124 | 3.220 |
Why?
|
| Catheter Ablation | 16 | 2023 | 252 | 2.120 |
Why?
|
| Heart Rate | 10 | 2023 | 493 | 1.560 |
Why?
|
| Atrial Fibrillation | 9 | 2021 | 350 | 1.410 |
Why?
|
| Electrocardiography | 9 | 2024 | 493 | 1.380 |
Why?
|
| Body Surface Potential Mapping | 5 | 2021 | 25 | 1.370 |
Why?
|
| Pericardium | 3 | 2021 | 70 | 1.350 |
Why?
|
| Heart Conduction System | 6 | 2021 | 112 | 1.270 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 6 | 2024 | 52 | 1.260 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2023 | 197 | 0.890 |
Why?
|
| Pacemaker, Artificial | 4 | 2021 | 94 | 0.860 |
Why?
|
| Heart Atria | 3 | 2021 | 281 | 0.820 |
Why?
|
| Endocardium | 2 | 2021 | 98 | 0.810 |
Why?
|
| Atrial Function, Left | 1 | 2021 | 50 | 0.780 |
Why?
|
| Heart Ventricles | 5 | 2020 | 779 | 0.770 |
Why?
|
| Defibrillators, Implantable | 4 | 2022 | 142 | 0.680 |
Why?
|
| Bundle of His | 4 | 2019 | 45 | 0.630 |
Why?
|
| Bundle-Branch Block | 4 | 2024 | 54 | 0.600 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 264 | 0.560 |
Why?
|
| Atrial Flutter | 4 | 2020 | 35 | 0.480 |
Why?
|
| Aged | 25 | 2024 | 19077 | 0.420 |
Why?
|
| Cardiac Resynchronization Therapy | 3 | 2022 | 68 | 0.390 |
Why?
|
| Male | 33 | 2024 | 42251 | 0.370 |
Why?
|
| Robotic Surgical Procedures | 1 | 2016 | 304 | 0.370 |
Why?
|
| Epicardial Mapping | 2 | 2021 | 10 | 0.370 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2018 | 98 | 0.330 |
Why?
|
| Device Removal | 2 | 2021 | 167 | 0.330 |
Why?
|
| Middle Aged | 25 | 2024 | 25863 | 0.300 |
Why?
|
| Humans | 38 | 2024 | 89063 | 0.270 |
Why?
|
| Predictive Value of Tests | 5 | 2021 | 1715 | 0.250 |
Why?
|
| Female | 28 | 2024 | 46011 | 0.250 |
Why?
|
| Cardiac Electrophysiology | 1 | 2024 | 7 | 0.240 |
Why?
|
| Prospective Studies | 10 | 2024 | 4273 | 0.230 |
Why?
|
| Cicatrix | 2 | 2023 | 68 | 0.230 |
Why?
|
| Physicians, Women | 1 | 2024 | 56 | 0.220 |
Why?
|
| Action Potentials | 3 | 2021 | 596 | 0.220 |
Why?
|
| Nadolol | 2 | 2020 | 4 | 0.210 |
Why?
|
| Flecainide | 2 | 2020 | 7 | 0.210 |
Why?
|
| Echocardiography | 2 | 2019 | 937 | 0.210 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 2 | 2019 | 19 | 0.200 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2019 | 65 | 0.200 |
Why?
|
| Ventricular Premature Complexes | 1 | 2021 | 8 | 0.200 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2021 | 10 | 0.190 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 2 | 2018 | 23 | 0.190 |
Why?
|
| Heart Failure | 2 | 2022 | 1180 | 0.190 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 60 | 0.190 |
Why?
|
| Vena Cava, Superior | 1 | 2020 | 60 | 0.180 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 54 | 0.170 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 3657 | 0.170 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 123 | 0.170 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 25 | 0.170 |
Why?
|
| Purkinje Fibers | 1 | 2019 | 27 | 0.170 |
Why?
|
| Heart Septum | 1 | 2019 | 47 | 0.170 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 25 | 0.170 |
Why?
|
| Sick Sinus Syndrome | 1 | 2018 | 9 | 0.160 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 70 | 0.160 |
Why?
|
| Precipitating Factors | 1 | 2018 | 5 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2022 | 6777 | 0.160 |
Why?
|
| Retrospective Studies | 10 | 2024 | 9003 | 0.160 |
Why?
|
| Baseball | 1 | 2018 | 18 | 0.160 |
Why?
|
| Feasibility Studies | 5 | 2021 | 779 | 0.160 |
Why?
|
| Atrioventricular Block | 1 | 2018 | 24 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 161 | 0.150 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 93 | 0.150 |
Why?
|
| Gene Deletion | 1 | 2019 | 342 | 0.150 |
Why?
|
| Atrioventricular Node | 1 | 2017 | 35 | 0.150 |
Why?
|
| Exons | 1 | 2019 | 451 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 786 | 0.130 |
Why?
|
| Risk Assessment | 4 | 2020 | 2290 | 0.130 |
Why?
|
| Hemorrhage | 1 | 2017 | 278 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2018 | 321 | 0.130 |
Why?
|
| Coronary Angiography | 1 | 2016 | 242 | 0.130 |
Why?
|
| Anticoagulants | 1 | 2017 | 426 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2015 | 169 | 0.110 |
Why?
|
| Hospitalization | 1 | 2018 | 876 | 0.110 |
Why?
|
| Hernia, Ventral | 1 | 2012 | 24 | 0.110 |
Why?
|
| Risk Factors | 7 | 2020 | 5466 | 0.110 |
Why?
|
| Treatment Outcome | 7 | 2022 | 8203 | 0.100 |
Why?
|
| Oseltamivir | 1 | 2011 | 20 | 0.100 |
Why?
|
| Inappropriate Prescribing | 1 | 2011 | 19 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 1239 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 104 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2011 | 346 | 0.080 |
Why?
|
| Thrombosis | 1 | 2011 | 302 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2011 | 337 | 0.080 |
Why?
|
| Incidence | 3 | 2018 | 1592 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2011 | 475 | 0.080 |
Why?
|
| Recurrence | 2 | 2019 | 1140 | 0.060 |
Why?
|
| Laparoscopy | 1 | 2012 | 771 | 0.060 |
Why?
|
| Pandemics | 1 | 2011 | 771 | 0.060 |
Why?
|
| Cardiologists | 1 | 2024 | 5 | 0.060 |
Why?
|
| Prevalence | 2 | 2018 | 1240 | 0.060 |
Why?
|
| Atropine | 1 | 2023 | 60 | 0.060 |
Why?
|
| Heart Block | 1 | 2023 | 31 | 0.060 |
Why?
|
| Adolescent | 4 | 2020 | 9237 | 0.060 |
Why?
|
| Mentors | 1 | 2024 | 85 | 0.050 |
Why?
|
| Career Choice | 1 | 2024 | 148 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 170 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2752 | 0.050 |
Why?
|
| Adult | 6 | 2021 | 26507 | 0.050 |
Why?
|
| Ventricular Fibrillation | 1 | 2021 | 68 | 0.050 |
Why?
|
| Prognosis | 2 | 2019 | 3773 | 0.050 |
Why?
|
| Sympathectomy | 1 | 2020 | 17 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 390 | 0.040 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 30 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2023 | 729 | 0.040 |
Why?
|
| Cardiac Catheters | 1 | 2019 | 12 | 0.040 |
Why?
|
| Exercise Test | 1 | 2020 | 165 | 0.040 |
Why?
|
| Indiana | 1 | 2019 | 13 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2020 | 296 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2019 | 27 | 0.040 |
Why?
|
| Patient Selection | 1 | 2022 | 682 | 0.040 |
Why?
|
| Malaysia | 1 | 2017 | 12 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2019 | 252 | 0.040 |
Why?
|
| United States | 2 | 2022 | 6955 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1710 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 2014 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2019 | 462 | 0.030 |
Why?
|
| Heart | 1 | 2020 | 573 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2017 | 682 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 595 | 0.030 |
Why?
|
| Stroke | 2 | 2017 | 982 | 0.030 |
Why?
|
| Ofloxacin | 1 | 1995 | 5 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 6288 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 237 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2024 | 1041 | 0.030 |
Why?
|
| Neutropenia | 1 | 1995 | 216 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 1063 | 0.030 |
Why?
|
| Fever | 1 | 1995 | 128 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1212 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 1995 | 187 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 2439 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1837 | 0.030 |
Why?
|
| United Arab Emirates | 1 | 2012 | 1 | 0.030 |
Why?
|
| Seroma | 1 | 2012 | 7 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2012 | 171 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2863 | 0.030 |
Why?
|
| Hematoma | 1 | 2012 | 108 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2012 | 122 | 0.020 |
Why?
|
| Herniorrhaphy | 1 | 2012 | 90 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 306 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 5320 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 684 | 0.020 |
Why?
|
| Length of Stay | 1 | 2012 | 732 | 0.020 |
Why?
|
| Chicago | 1 | 2011 | 1423 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 2275 | 0.010 |
Why?
|
| Child | 1 | 2011 | 7149 | 0.010 |
Why?
|
| Neoplasms | 1 | 1995 | 3035 | 0.010 |
Why?
|
| Fever of Unknown Origin | 1 | 1995 | 4 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1995 | 1533 | 0.010 |
Why?
|